Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica / Clinical usefulness of biomarkers in cardiac failure
Rev. méd. Chile
;
141(12): 1560-1569, dic. 2013. tab
Article
in Spanish
| LILACS
| ID: lil-705576
ABSTRACT
The assessment of patients with a suspected cardiac failure aims to an early and precise diagnosis and risk stratification. Only natriuretic peptides have demonstrated to be clinically useful. Brain natriuretic peptide stands out due to its diagnostic and prognostic value. However its results should be cautiously interpreted in the clinical context, bearing in mind possible confounders. The combination of markers can provide a better risk stratification and compensates the limitations of individual markers. Each new marker gives a new insight on the underlying physiopathology of cardiac failure and proposes new therapeutic approaches.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Biomarkers
/
Heart Failure
Type of study:
Etiology study
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2013
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Pontificia Universidad Católica de Chile/CL
Similar
MEDLINE
...
LILACS
LIS